HRP20181933T1 - Farmaceutski postupak i intermedijari - Google Patents

Farmaceutski postupak i intermedijari

Info

Publication number
HRP20181933T1
HRP20181933T1 HRP20181933TT HRP20181933T HRP20181933T1 HR P20181933 T1 HRP20181933 T1 HR P20181933T1 HR P20181933T T HRP20181933T T HR P20181933TT HR P20181933 T HRP20181933 T HR P20181933T HR P20181933 T1 HRP20181933 T1 HR P20181933T1
Authority
HR
Croatia
Prior art keywords
intermediates
pharmaceutical process
pharmaceutical
Prior art date
Application number
HRP20181933TT
Other languages
English (en)
Inventor
Benedict MCKEEVER
Louis Joseph Diorazio
Martin Francis Jones
Leigh FERRIS
Sophie Laure Marie Janbon
Pawel Stanislaw Siedlecki
Gwydion Huw Churchill
Peter Alan Crafts
Original Assignee
Rigel Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals, Inc. filed Critical Rigel Pharmaceuticals, Inc.
Publication of HRP20181933T1 publication Critical patent/HRP20181933T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
HRP20181933TT 2013-12-20 2018-11-20 Farmaceutski postupak i intermedijari HRP20181933T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361919671P 2013-12-20 2013-12-20
EP14828102.5A EP3083648B1 (en) 2013-12-20 2014-12-19 Pharmaceutical process and intermediates
PCT/US2014/071613 WO2015095765A1 (en) 2013-12-20 2014-12-19 Pharmaceutical process and intermediates

Publications (1)

Publication Number Publication Date
HRP20181933T1 true HRP20181933T1 (hr) 2019-01-11

Family

ID=52358996

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181933TT HRP20181933T1 (hr) 2013-12-20 2018-11-20 Farmaceutski postupak i intermedijari

Country Status (16)

Country Link
US (2) US9388203B2 (hr)
EP (1) EP3083648B1 (hr)
JP (1) JP6522005B2 (hr)
CN (1) CN105849115B (hr)
CA (2) CA2934535C (hr)
CY (1) CY1121313T1 (hr)
DK (1) DK3083648T3 (hr)
ES (1) ES2701088T3 (hr)
HR (1) HRP20181933T1 (hr)
HU (1) HUE042204T2 (hr)
LT (1) LT3083648T (hr)
PL (1) PL3083648T3 (hr)
PT (1) PT3083648T (hr)
RS (1) RS58084B1 (hr)
SI (1) SI3083648T1 (hr)
WO (1) WO2015095765A1 (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109912622A (zh) * 2019-03-20 2019-06-21 中国药科大学 一种福他替尼关键中间体的制备方法及其中间体和利用中间体制备福他替尼的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016893A2 (en) 2003-07-30 2005-02-24 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
RU2416616C2 (ru) * 2005-01-19 2011-04-20 Райджел Фармасьютикалз, Инк. Пролекарства соединений 2,4-пиримидиндиамина и их применения
CA2673137C (en) * 2006-11-21 2015-02-10 Rigel Pharmaceuticals, Inc. Prodrug salts of 2,4-pyrimidinediamine compounds and their uses
UA108077C2 (xx) * 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
ES2524127T3 (es) * 2009-11-20 2014-12-04 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidinodiamina y sus profármacos y sus usos

Also Published As

Publication number Publication date
RS58084B1 (sr) 2019-02-28
CN105849115B (zh) 2019-06-11
ES2701088T3 (es) 2019-02-20
EP3083648A1 (en) 2016-10-26
SI3083648T1 (sl) 2019-02-28
DK3083648T3 (en) 2019-01-07
JP2017503018A (ja) 2017-01-26
US9388203B2 (en) 2016-07-12
US20150175639A1 (en) 2015-06-25
PL3083648T3 (pl) 2019-05-31
JP6522005B2 (ja) 2019-05-29
CA2934535C (en) 2023-03-28
WO2015095765A1 (en) 2015-06-25
EP3083648B1 (en) 2018-09-12
HUE042204T2 (hu) 2019-06-28
US20160355531A1 (en) 2016-12-08
LT3083648T (lt) 2019-01-25
US9695204B2 (en) 2017-07-04
CN105849115A (zh) 2016-08-10
PT3083648T (pt) 2018-12-14
CY1121313T1 (el) 2020-05-29
CA3186267A1 (en) 2015-06-25
CA2934535A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
HK1219663A1 (zh) 藥物組合
GB201520943D0 (en) Novel linker and preparation method thereof
GB201309173D0 (en) Novel process and product
SG11201508447TA (en) Expression process
GB201301639D0 (en) Product and process
SI2943561T1 (sl) Fotobioreaktor
IL242943A0 (en) A process for the preparation of abiraterone and its intermediates
GB201323132D0 (en) New products and processes
HUP1300033A2 (en) Improved process for producing pharmaceutical agent and intermediate
HK1204916A1 (en) Pharmaceutical application of anhydroicaritin
HRP20181933T1 (hr) Farmaceutski postupak i intermedijari
HK1217323A1 (zh) 異己糖醇單三氟甲磺酸酯及其合成方法
SG11201602693QA (en) Methods and intermediates for preparing macrolactams
HUP1300722A2 (en) Norsteroid intermediates and process for their preparation
GB201321103D0 (en) Novel process and products
GB201318453D0 (en) Novel method and products
GB201317888D0 (en) Method and product
GB201310496D0 (en) Pharmaceutical combinations
GB201304585D0 (en) Methods and product
GB201301723D0 (en) Pharmaceutical combinations
GB201321442D0 (en) Expression process
GB201320339D0 (en) Expression Process
GB201319930D0 (en) Expression process
GB201300358D0 (en) Method and product
GB201316662D0 (en) Pharmaceutical Combination